Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The adrenocorticotropic hormone receptor (ACTHR), also known as melanocortin 2 receptor (MC2R), is a G protein-coupled receptor primarily expressed in the adrenal cortex. It is highly specific for its endogenous ligand, adrenocorticotropic hormone (ACTH), and plays a central role in regulating adrenal steroidogenesis. Mutations or dysfunctions associated with MC2R can lead to familial glucocorticoid deficiency type 1. Long-term overstimulation can contribute to Cushing's syndrome-like symptoms if used therapeutically.
ACTH binding activates Gs protein, leading to increased cAMP, PKA activation, and ultimately, increased steroidogenic enzyme expression and glucocorticoid synthesis.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adrenocorticotropic Hormone Receptor (ACTHR).